Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Explore this paper's citation graph
- Type
- review
- Published
- 2014-02-01
- Cited by
- 4,624
- References
- 54
- Access
- Open access
- OpenAlex
- https://openalex.org/W2160226180
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:35014672
Keywords
Macular degeneration, Medicine, Demography, Population, Epidemiology
References
- Genetic studies of Age-related macular degeneration: lessons, challenges and opportunities for disease management
- Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors.
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- Prevalence of age-related macular degeneration in the United States.
- Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study.
- Risk factors for age-related macular degeneration: Pooled findings from three continents.
- The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.
- The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent.
- Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.
- Prevalence and risk factors for age-related macular degeneration in Indians: a comparative study in Singapore and India.
- Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
- Clinical update: new treatments for age-related macular degeneration.
- Forecasting age-related macular degeneration through 2050.
- Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study.
- Cataracts and macular degeneration in older Americans.
- The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis.
- Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration.
- Ranibizumab in neovascular age-related macular degeneration
- Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study.
- Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study.
Cited by
- Essential hypertension in the pathogenesis of age-related macular degeneration: a review of the current evidence.
- Hyperspectral Autofluorescence Imaging of Drusen and Retinal Pigment Epithelium in Donor Eyes with Age-Related Macular Degeneration
- Complement Factor H Inhibits CD47‐Mediated Resolution of Inflammation
- Visual Function Quality of Life Measure Changes Upon Conversion to Neovascular Age-Related Macular Degeneration in Second Eyes
- Autophagy regulates Endothelial-Mesenchymal transition by decreasing the phosphorylation level of Smad3.
- Involvement of a gut–retina axis in protection against dietary glycemia-induced age-related macular degeneration
- Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration.
- Genetic risk factors for late age-related macular degeneration in India
- Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population
- APR3 modulates oxidative stress and mitochondrial function in ARPE‐19 cells
- Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells
- Prevalence of Subclinical CNV and Choriocapillaris Nonperfusion in Fellow Eyes of Unilateral Exudative AMD on OCT Angiography
- Complement inhibition as a therapeutic strategy in retinal disorders
- Lack of Delta-Sarcoglycan (Sgcd) Results in Retinal Degeneration
- Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions
- Long term outcomes in dry age-related macular degeneration following low vision rehabilitation interventions
- Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services.
- Oxidative stress-related damage of retinal pigment epithelial cells : possible protective properties of autophagocytosed iron-binding proteins
- Human retinal pigment epithelial cell proliferation by the combined stimulation of hydroquinone and advanced glycation end-products via up-regulation of VEGF gene
- INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend Trial
Related papers
- Sub Macular Hemorrhage in Age Related Macular Degeneration
- Real-world UK NHS outcomes of a switch to Aflicercept from Ranibizumab in Neovascular age related macular degeneration (nvAMD).
- Barriers to care in neovascular age-related macular degeneration: Current understanding, developments, and future directions.
- Age-related macular degeneration
- PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- Age-related macular degeneration.
- Vision-Related Quality of Life in Subjects With Neovascular Age-Related Macular Degeneration (NV-AMD): A Comparison of Early and Established CNV Lesions
- VITAMIN D DEFICIENCY IN NEOVASCULAR VERSUS NONNEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- Macugen Monotherapy in Newly Diagnosed Neovascular Age-Related Macular Degeneration (AMD)
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration